PROVIDER PROFILE · NPI 1124679725

Aprille Mangalonzo

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

484

Beneficiaries

—

Total drug cost

$11K

Distinct drugs

Brand share

18.6%

Top prescribed drugs

QUALITY · MIPS · 2024

Final MIPS score

91.7

Quality

88.4

Cost

68.9

Improvement activities

40.0

Promoting interop.

78.0

Payment adjustment

0.70%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital

CROSS-REFERENCE